AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
πΏπΌ
MIDAZOLAM in Zimbabwe
1 product registered with MCAZ β 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| MEZOLAM SOLUTION; INJECTION | 2025/13.2.2/7211 | ARAVAS PHARMACEUTICALS | active | 14 Nov 2030 |
MIDAZOLAM β MCAZ Registration Details
MCAZ (Zimbabwe) has 1 registered product containing MIDAZOLAM, of which 1 is currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track MIDAZOLAM registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.